Meningococcal Vaccines Market SWOT Analysis by Key Players: Pfizer, Sanofi, CanSino Biologics, GlaxoSmithKline

A new independent 120 page research with title 'Meningococcal Vaccines - Global Drug Forecast and Market Analysis to 2029' guarantees you will remain better informed than your competition. The study covers geographic analysis that includes regions and important players/vendors such as GlaxoSmithKline, Pfizer, Sanofi, CanSino Biologics, Beijing Tiantan Biological Products, Lanzhou Institute of Biological Products, Shanghai Institute of Biological Products, Shenzhen Sanofi Pasteur Biological Products, Walvax Biotechnology, Wuhan Institute of Biological Products. With n-number of tables and figures examining the Meningococcal Vaccines, the research gives you a visual, one-stop breakdown of the leading products, submarkets and market leader’s market revenue forecasts as well as analysis to 2026

Get customization & check discount for report @ https://www.htfmarketreport.com/request-discount/2909294-meningococcal-vaccines-global-drug-forecast-and-market

Summary

Meningococcal disease is an infection caused by Neisseria meningitidis bacteria, and, although relatively rare, is widely feared because of its high mortality rate even in otherwise healthy individuals. Serogroups A, B, C, W, and Y are the most common meningococcal types in the nine major markets (9MM) covered in this report (US, France, Germany, Italy, Spain, UK, Argentina, Brazil, and China), and immunization of high-risk groups such as infants and adolescents provides the best protection against the infection. Immunization with conjugated meningococcal serogroup C (MenC) is routinely recommended for infants in the 5EU and Brazil, and immunization against serogroup ACWY (MenACWY vaccines) is recommended in the US, UK, Italy, and Spain for adolescents, and in Argentina for infants. In China, immunization with polysaccharide MenA and MenAC vaccines is routinely recommended for infants and young children.

Sanofi, GSK, and Pfizer are the major players in the meningococcal vaccine market, with GSK and Pfizer providing vaccines in each category, while Sanofi is offering only MenACWY vaccines. A major unmet need remains in a vaccine that combines the protection against all five serogroups most common in the 9MM.

Key Questions Answered

- How will the meningococcal vaccine market landscape in the 9MM (US, France, Germany, Italy, Spain, UK, Argentina, Brazil, China) change from 2019-2029?
- What are the most promising late-stage pipeline products for meningococcal vaccination?
- How do the clinical and commercial attributes of late-stage pipeline products compare with one another, and against existing immunization options?
- What are the remaining unmet needs in meningococcal immunization?
- What drivers and barriers will affect meningococcal vaccine sales in the 9MM over the forecast period?

Request a sample report @ https://www.htfmarketreport.com/sample-report/2909294-meningococcal-vaccines-global-drug-forecast-and-market
Scope

- Overview of meningococcal disease, including epidemiology, etiology, pathophysiology, symptoms, diagnosis, and current management strategies.
- Topline meningococcal vaccine market revenue from 2019-2029. Annual cost of immunization and major pipeline product sales in this forecast period are included.
- Key topics covered include current vaccination options, unmet needs and opportunities, and the drivers and barriers affecting meningococcal vaccine sales in the 9MM.
- Pipeline analysis: comprehensive data split across different phases, emerging novel trends under development, synopses of innovative early-stage projects, and detailed analysis of late-stage pipeline products.
- Analysis of the current and future market competition in the global meningococcal vaccine market. Insightful review of the key industry drivers, constraints, and challenges. Each trend is independently researched to provide qualitative analysis of its implications.

Reasons to Buy

The report will enable you to -
- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
- Develop business strategies by understanding the trends shaping and driving the global meningococcal vaccine market.
- Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the meningococcal vaccine market in the future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
- Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.

Companies Mentioned in the Report

GlaxoSmithKline
Pfizer
Sanofi
CanSino Biologics
Beijing Tiantan Biological Products
Lanzhou Institute of Biological Products
Shanghai Institute of Biological Products
Shenzhen Sanofi Pasteur Biological Products
Walvax Biotechnology
Wuhan Institute of Biological Products

View Detailed Table of Content @ https://www.htfmarketreport.com/reports/2909294-meningococcal-vaccines-global-drug-forecast-and-market

1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Meningococcal Vaccines: Executive Summary
2.1 Modest Growth Expected for the Meningococcal Vaccines Market over the Forecast Period, 2019-2029
2.2 Multivalent Meningococcal Vaccines Will Shape the Market During the Forecast Period to 2029
2.3 Multivalent MenACWY Vaccines Will Provide Broader Protection While Reducing the Vaccine Burden and Being More Cost-effective
2.4 The Anticipated Launches of Pentavalent MenABCWY Vaccines in 2024 Will Slowly Change the Meningococcal Vaccine Competitive Landscape
2.5

....Continued

Place a Purchase Order for this Market Study (Single User License) at: https://www.htfmarketreport.com/buy-now?format=1&report=2909294

Thanks for reading this article, you can also get individual chapter wise section or region wise report version like North America, Europe or Asia.

Contact US :
Craig Francis (PR & Marketing Manager)
HTF Market Intelligence Consulting Private Limited
Unit No. 429, Parsonage Road Edison, NJ
New Jersey USA – 08837
Phone: +1 (206) 317 1218
sales@htfmarketreport.com

Connect with us at LinkedIn | Facebook | Twitter

HTF Market Report is a wholly owned brand of HTF market Intelligence Consulting Private Limited. HTF Market Report global research and market intelligence consulting organization is uniquely positioned to not only identify growth opportunities but to also empower and inspire you to create visionary growth strategies for futures, enabled by our extraordinary depth and breadth of thought leadership, research, tools, events and experience that assist you for making goals into a reality. Our understanding of the interplay between industry convergence, Mega Trends, technologies and market trends provides our clients with new business models and expansion opportunities. We are focused on identifying the “Accurate Forecast” in every industry we cover so our clients can reap the benefits of being early market entrants and can accomplish their “Goals & Objectives”.

This release was published on openPR.